Evidence map›Paper›PMID 38466267›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

The Positioning of Ceftobiprole in Staphylococcus aureus Bacteremia.

Francisco Javier Membrillo de Novales, Olga Bravo de Pablo, Ángel Estella, Laura Morata Ruiz, Maria Rosa Oltra Sempere, Miguel Salavert Lleti, Miriam Estébanez Muñoz, Carmen Hidalgo-Tenorio

Abstract readEditorialComment
PubMed Publisher
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Francisco Javier Membrillo de NovalesCBRN and Infectious Diseases Department, Hospital Central de la Defensa "Gómez Ulla", Spain.ORCID 0000-0002-5330-5540
Olga Bravo de PabloInternal Medicine Department, Hospital La Moraleja, Madrid, Spain.
Ángel EstellaIntensive Care Department, University of Cádiz, Instituto de Investigación e Innovación Biomédica de Cádiz, Hospital Universitario de Jerez, Spain.ORCID 0000-0003-0665-557X
Laura Morata RuizInfectious Diseases Department, Hospital Clinic, Barcelona, Spain.ORCID 0000-0001-5795-0814
Maria Rosa Oltra SempereInfectious Diseases Unit, Hospital Clinic Universitari Valencia, Spain.
Miguel Salavert LletiInfectious Diseases Department, Hospital La Fe, Valencia, Spain.ORCID 0000-0002-8571-2124
Miriam Estébanez MuñozCBRN and Infectious Diseases Department, Hospital Central de la Defensa "Gómez Ulla", Spain.ORCID 0000-0003-4509-9123
Carmen Hidalgo-TenorioInfectious Diseases Unit, Hospital Virgen de las Nieves, Granada, Spain.ORCID 0000-0002-6394-5728

Funding

Fundación SEIMC-GESIDA
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38466267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.